Abstract
Image-guided percutaneous ablation therapy for hepatocellular carcinoma has been used worldwide, and the most widely used modalities are radiofrequency ablation (RF) and microwave ablation (MA). Multiphasic contrast-enhanced CT, dynamic MRI, and contrast-enhanced ultrasound are accepted as reliable modalities for evaluating the adequacy of radiofrequency and microwave ablation and early detection of tumor recurrences. In this session, we evaluate the clinical utility of low mechanical index contrast-enhanced ultrasound in assessing percutaneous microwave ablation response in patients with hepatocellular carcinoma by comparing the results to contrast-enhanced magnetic resonance imaging and prove that contrast-enhanced ultrasound examination is a safe and easy modality in assessing therapeutic effect of microwave ablation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tang Z-Y. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol. 2006;7:445–54.
Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg. 1995;221:291–8.
Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171–9.
Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology. 2005;235:299–307.
Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound. 2001;13:149–58.
Antoch G, Kuehl H, Vogt FM, Debatin JF, Stattaus J. Value of CT volume imaging for optimal placement of radiofrequency ablation probes in liver lesions. J Vasc Interv Radiol. 2002;13:1155–61.
Kono Y, Lucidarme O, Choi SH. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2007;18(1 Pt 1):57–65.
Schneider M, Arditi M, Barrau MB, Brochot J, Broillet A, Ventrone R, Yan F. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol. 1995;30(8):451–7.
Liang P, Dong B, Yu X, Yang Y, Yu D, Su L, Xiao Q, Sheng L. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol. 2003;181:1319–25.
Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z, Zhang J. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol. 2003;180:1547–55.
Zhou P, Liang P, Yu X, Wang Y, Dong B. Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract. J Gastrointest Surg. 2009;13:318–24.
Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation-complications among cohort of 1136 patients. Radiology. 2009;251(3):933–40. Epub 2009 Mar 20.
Kondo H, Kanematsu M, Hoshi H, et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR. 2000;174:947–54.
Takahiro D, Ei K, Ikuhiro Y, Kouichi M, Shigetoshi O, Tomomi S, Daisuke S, Wataru S, Yumiko A, Hajime I, Kentaro K, Takashi G, Hirohide O. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma. Intern Med. 2012;51(1):1–7. Epub 2012 Jan 1.
Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR. 2000;174:323–31.
Lencioni R, Cioni D, Goletti O, et al. Radiofrequency thermal ablation of liver tumors: state-of-the-art. Cancer J. 2000;6 suppl 4:S304–15.
Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging. 2001;26:345–36.
Sironi S, Livraghi T, Meloni F, De Cobelli F, Ferrero C, Del Maschio A. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR. 1999;173:1225–9.
Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. Hepatic tumor treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255–62.
Chopra S, Dodd III GD, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol. 2001;177:381–7.
Vogl TJ, Schwarz W, Blume S, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol. 2003;13:262–72.
Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology. 1999;213:86–91.
Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, Servadio G, Rizzatto G, Mueller PR, Del Maschio A, Gazelle GS. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 1997;202:195.
Livraghi T, Goldberg SN, Monti F, Bizzini A, Lazzaroni S, Meloni F, Pellicanò S, Solbiati L, Gazelle GS. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology. 1997;202:582.
Tsuda M, Majima K, Yamada T, et al. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging. 2001;25:409–15.
Darby S, Berrington de Gonza’lez A. Risk of from diagnostic X-rays; estimates for the UK and 14 other countries. Lancet. 2004;363.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Qu, P. et al. (2015). Application of Contrast-Enhanced Ultrasound in the Evaluation of Clinical Effect of Microwave Ablation of Hepatocellular Carcinoma: Comparison with Other Imaging Modalities. In: Liang, P., Yu, Xl., Yu, J. (eds) Microwave Ablation Treatment of Solid Tumors. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9315-5_30
Download citation
DOI: https://doi.org/10.1007/978-94-017-9315-5_30
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9314-8
Online ISBN: 978-94-017-9315-5
eBook Packages: MedicineMedicine (R0)